High throughput screening of protein formulation stability: Practical considerations

被引:97
作者
Capelle, Martinus A. H. [1 ]
Gurny, Robert [1 ]
Arvinte, Tudor [1 ]
机构
[1] Univ Geneva, Univ Lausanne, Dept Pharmaceut & Biopharmaceut, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
关键词
high throughput screening; protein formulation; spectroscopy; physical and chemical characterization; fluorescence; aggregation; stability;
D O I
10.1016/j.ejpb.2006.09.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The formulation of protein drugs is a difficult and time-consuming process, mainly due to the complexity of protein structure and the very specific physical and chemical properties involved. Understanding protein degradation pathways is essential for the success of a biopharmaceutical drug. The present review concerns the application of high throughput screening techniques in protein formulation development. A protein high throughput formulation (HTF) platform is based on the use of microplates. Basically, the HTF platform consists of two parts: (i) sample preparation and (ii) sample analysis. Sample preparation involves automated systems for dispensing the drug and the formulation ingredients in both liquid and powder form. The sample analysis involves specific methods developed for each protein to investigate physical and chemical properties of the formulations in microplates. Examples are presented of the use of protein intrinsic fluorescence for the analysis of protein aqueous properties (e.g., conformation and aggregation). Different techniques suitable for HTF analysis are discussed and some of the issues concerning implementation are presented with reference to the use of microplates. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 148
页数:18
相关论文
共 171 条
[61]   An absorption detection approach for multiplexed capillary electrophoresis using a linear photodiode array [J].
Gong, XY ;
Yeung, ES .
ANALYTICAL CHEMISTRY, 1999, 71 (21) :4989-4996
[62]   Resonance energy transfer between tryptophan-214 in human serum albumin and acrylodan, prodan, and promen [J].
González-Jiménez, J ;
Cortijo, M .
PROTEIN JOURNAL, 2004, 23 (05) :351-355
[63]   Fluorescence readouts in HTS: no gain without pain? [J].
Gribbon, P ;
Sewing, A .
DRUG DISCOVERY TODAY, 2003, 8 (22) :1035-1043
[64]  
Gupta S, 2003, AAPS PHARMSCI, V5
[65]   A fluorescence microscopy based genetic screen to identify mutants altered for interactions with host cells [J].
Guy, RL ;
Gonias, LA ;
Stein, MA .
JOURNAL OF MICROBIOLOGICAL METHODS, 2000, 42 (02) :129-138
[66]  
Hail Mark E., 2004, American Biotechnology Laboratory, V22, P12
[67]   Single-molecule detection technologies in miniaturized high-throughput screening:: Fluorescence intensity distribution analysis [J].
Haupts, U ;
Rüdiger, M ;
Ashman, S ;
Turconi, S ;
Bingham, R ;
Wharton, C ;
Hutchinson, J ;
Carey, C ;
Moore, KJ ;
Pope, AJ .
JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (01) :19-33
[68]   High-throughput screening of kinase inhibitors by multiplex capillary electrophoresis with UV absorption detection [J].
He, Y ;
Yeung, ES .
ELECTROPHORESIS, 2003, 24 (1-2) :101-108
[69]  
Helfrich JP, 2001, AM LAB, V33, P24
[70]   High-throughput screening: new technology for the 21st century [J].
Hertzberg, RP ;
Pope, AJ .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (04) :445-451